Uveitis Clinical Trial Analysis by Trial Phase, Trial Status, Trial Counts, End Points, Status, Sponsor Type, and Top Countries, 2023 Update
- $ 2500
- May 2024
- 269 pages
(C-C Motif Chemokine ## (HC11 or Monocyte Chemoattractant Protein ## or Monocyte Chemotactic And Activating Factor or MCAF or Monocyte Chemotactic Protein ## or Monocyte Secretory Protein JE or Small Inducible Cytokine A2 or CCL2), Cytokine, Interferon Gamma (Immune Interferon or IFNG), Interleukin ## Alpha (IL ## Alpha or Hematopoietin ## or IL1A), Interleukin ## Beta (IL ## Beta or Catabolin or IL1B), Interleukin ## (Cytokine Synthesis Inhibitory Factor or CISF or IL10), Interleukin ## (IL12), Interleukin ## (IL13), Interleukin ## (IL15), Interleukin ## (IL17), Interleukin ## (T Cell Growth Factor or Aldesleukin or IL2), Interleukin ## (IL23), Interleukin ## (B Cell Stimulatory Factor ## or Binetrakin or Lymphocyte Stimulatory Factor ## or Pitrakinra or IL4), Interleukin ## (Eosinophil Differentiation Factor or B Cell Differentiation Factor I or T Cell Replacing Factor or IL5), Interleukin ## (B Cell Stimulatory Factor ## or BSF2 or CTL Differentiation Factor or CDF or Hybridoma Growth Factor or Interferon Beta ## or IFNB2 or IL6), Interleukin ## (IL8 or C- X-C Motif Chemokine ## or Emoctakin or Granulocyte Chemotactic Protein ## or GCP1 or Monocyte Derived Neutrophil Chemotactic Factor or MDNCF or Monocyte Derived Neutrophil Activating Peptide or MONAP or Neutrophil Activating Protein ## or NAP1 or T Cell Chemotactic Factor or CXCL8), Vascular Endothelial Growth Factor (VEGF) )